![]() One important and still unresolved issue concerns the true incidence and prevalence of IPF and, consequently, the total number of affected patients in Brazil. ![]() In particular, health-related governmental decisions should be based on robust epidemiological data, and, unfortunately, there are few such data on IPF in Brazil. We are seeing the beginning of a new era in the care of IPF patients, which is promising but also implies additional needs and concerns. In addition, clinical trials are underway to investigate new drugs with different mechanisms of action. Now it is clear that both drugs reduce the rate of decline in pulmonary function in individuals affected by the disease. However, in late 2014, the US Food and Drug Administration approved two new drugs for the treatment of patients with this disease. ![]() The treatment of IPF has always been a challenge. Patients with IPF usually experience progressive loss of pulmonary function and severely impaired quality of life, evolving to death. ![]() Idiopathic pulmonary fibrosis (IPF) is a form of chronic fibrosing interstitial pneumonia of unknown etiology that primarily affects the elderly and for which usual interstitial pneumonia is the substrate.
0 Comments
Leave a Reply. |